이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Shandong Weigao Group Medical Polymer 미래 성장
Future 기준 확인 1/6
Shandong Weigao Group Medical Polymer (는) 각각 연간 10.4% 및 7.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 10.1% 로 예상됩니다.
주요 정보
10.4%
수익 성장률
10.3%
EPS 성장률
| Medical Equipment 수익 성장 | 34.7% |
| 매출 성장률 | 7.5% |
| 향후 자기자본 수익률 | 10.1% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 14 May 2024 |
최근 미래 성장 업데이트
Recent updates
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk
Jun 25
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return
Jun 23Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope
May 22Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Apr 23Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results
Mar 28Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon
Jan 09Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 22Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?
Nov 10Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Oct 05Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing
Aug 01Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?
Jul 19Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Jun 22Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?
Jun 09The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Apr 27Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Feb 27Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes
Jan 18Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Dec 12Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate
Nov 29Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Nov 14Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year
Oct 03The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Sep 21Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt
Sep 05Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price
Aug 23Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors
Aug 08There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital
Jun 22Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year
Jun 08An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued
May 16Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
May 03Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher
Mar 17Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?
Jan 28Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?
Jan 13Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 17Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly
Dec 05An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued
Oct 18Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?
Oct 06Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue
Sep 10Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet
Aug 29Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Jul 09Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Jun 26Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)
Jun 02These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well
Apr 24수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 16,585 | 2,744 | 3,136 | 3,525 | 6 |
| 12/31/2025 | 15,323 | 2,450 | 2,285 | 3,066 | 8 |
| 12/31/2024 | 14,174 | 2,204 | 1,897 | 1,835 | 8 |
| 12/31/2023 | 13,229 | 2,002 | 2,113 | 2,799 | N/A |
| 9/30/2023 | 13,398 | 2,221 | 1,639 | 2,539 | N/A |
| 6/30/2023 | 13,438 | 2,399 | 1,086 | 2,199 | N/A |
| 3/31/2023 | 13,529 | 2,561 | 1,094 | 2,207 | N/A |
| 12/31/2022 | 13,747 | 2,764 | 1,181 | 2,295 | N/A |
| 9/30/2022 | 13,903 | 2,676 | 1,433 | 2,573 | N/A |
| 6/30/2022 | 14,058 | 2,589 | 1,685 | 2,852 | N/A |
| 3/31/2022 | 13,633 | 2,432 | 1,803 | 2,969 | N/A |
| 12/31/2021 | 13,209 | 2,276 | 1,920 | 3,087 | N/A |
| 9/30/2021 | 12,923 | 2,288 | 2,021 | 3,088 | N/A |
| 6/30/2021 | 12,636 | 2,300 | 2,121 | 3,089 | N/A |
| 3/31/2021 | 12,129 | 2,194 | 1,971 | 2,938 | N/A |
| 12/31/2020 | 11,622 | 2,087 | 1,821 | 2,788 | N/A |
| 9/30/2020 | 11,139 | 1,998 | 1,557 | 2,533 | N/A |
| 6/30/2020 | 10,656 | 1,909 | 1,292 | 2,277 | N/A |
| 3/31/2020 | 10,520 | 1,879 | 1,315 | 2,300 | N/A |
| 12/31/2019 | 10,384 | 1,850 | 1,337 | 2,322 | N/A |
| 9/30/2019 | 9,993 | 1,805 | 1,456 | 2,347 | N/A |
| 6/30/2019 | 9,602 | 1,760 | 1,575 | 2,371 | N/A |
| 3/31/2019 | 9,205 | 1,616 | 1,500 | 2,295 | N/A |
| 12/31/2018 | 8,809 | 1,473 | 1,424 | 2,219 | N/A |
| 6/30/2018 | 7,465 | 1,255 | 383 | 1,812 | N/A |
| 3/31/2018 | 6,879 | 1,255 | 110 | 1,539 | N/A |
| 12/31/2017 | 6,293 | 1,255 | -163 | 1,266 | N/A |
| 6/30/2017 | 5,402 | 1,297 | N/A | 1,233 | N/A |
| 3/31/2017 | 5,511 | 1,165 | N/A | 1,143 | N/A |
| 12/31/2016 | 5,620 | 1,033 | N/A | 1,053 | N/A |
| 9/30/2016 | 6,484 | 1,010 | N/A | 1,042 | N/A |
| 6/30/2016 | 6,237 | 914 | N/A | 1,030 | N/A |
| 3/31/2016 | 6,078 | 1,013 | N/A | 1,041 | N/A |
| 12/31/2015 | 5,919 | 1,113 | N/A | 1,053 | N/A |
| 9/30/2015 | 5,878 | 1,237 | N/A | N/A | N/A |
| 6/30/2015 | 5,610 | 1,196 | N/A | 622 | N/A |
| 3/31/2015 | 5,548 | 1,161 | N/A | N/A | N/A |
| 12/31/2014 | 5,278 | 1,085 | N/A | 711 | N/A |
| 9/30/2014 | 5,011 | 307 | N/A | N/A | N/A |
| 6/30/2014 | 4,996 | 431 | N/A | 794 | N/A |
| 3/31/2014 | 4,769 | 376 | N/A | N/A | N/A |
| 12/31/2013 | 4,613 | 388 | N/A | 720 | N/A |
| 9/30/2013 | 4,230 | 1,007 | N/A | N/A | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 1066 의 연간 예상 수익 증가율( 10.4% )이 saving rate( 2.2% 보다 높습니다. ).
수익 vs 시장: 1066 의 연간 수익( 10.4% ) Hong Kong 시장( 11.7% 보다 느리게 성장할 것으로 예상됩니다. 11.7% 연간).
고성장 수익: 1066 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: 1066 의 수익(연간 7.5% ) Hong Kong 시장( 7.8% 보다 느리게 성장할 것으로 예상됩니다. 7.8% 연간).
고성장 수익: 1066 의 수익(연간 7.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: 1066 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 10.1 %).